As of 2025-05-23, the Intrinsic Value of IDEXX Laboratories Inc (IDXX) is 486.82 USD. This IDXX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 504.83 USD, the upside of IDEXX Laboratories Inc is -3.60%.
The range of the Intrinsic Value is 290.17 - 1,656.19 USD
Based on its market price of 504.83 USD and our intrinsic valuation, IDEXX Laboratories Inc (IDXX) is overvalued by 3.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 290.17 - 1,656.19 | 486.82 | -3.6% |
| DCF (Growth 10y) | 350.55 - 1,868.85 | 570.50 | 13.0% |
| DCF (EBITDA 5y) | 286.01 - 440.88 | 349.97 | -30.7% |
| DCF (EBITDA 10y) | 346.22 - 548.73 | 428.92 | -15.0% |
| Fair Value | 187.14 - 187.14 | 187.14 | -62.93% |
| P/E | 360.90 - 528.98 | 457.95 | -9.3% |
| EV/EBITDA | 215.02 - 409.46 | 330.23 | -34.6% |
| EPV | 116.26 - 162.81 | 139.53 | -72.4% |
| DDM - Stable | 155.43 - 1,157.72 | 656.57 | 30.1% |
| DDM - Multi | 240.18 - 1,400.90 | 411.08 | -18.6% |
| Market Cap (mil) | 40,911.42 |
| Beta | 0.71 |
| Outstanding shares (mil) | 81.04 |
| Enterprise Value (mil) | 41,687.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.92% |
| Cost of Debt | 8.83% |
| WACC | 6.92% |